Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nurses and fight against tuberculosis

M M Puri1, T John

  • 1L.R.S. Institute of Tuberculosis and Allied Diseases, New Delhi.

The Nursing Journal of India
|October 26, 1999
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Oxidantscan: A novel biomarker to assess red blood cell susceptibility to oxidative stress in sickle cell disease.

Blood cells, molecules & diseases·2025
Same author

Second-line treatment strategies and clinical outcomes after progression on chemoimmunotherapy in extensive-stage small-cell lung cancer.

Lung cancer (Amsterdam, Netherlands)·2025
Same author

Impacts of a Clinical Quality Registry on Lung Cancer Quality Measures: A Retrospective Observational Study of the Victorian Lung Cancer Registry.

Clinical oncology (Royal College of Radiologists (Great Britain))·2025
Same author

Nivolumab plus ipilimumab with chemotherapy as first-line treatment of patients with metastatic non-small-cell lung cancer: final, 6-year outcomes from CheckMate 9LA.

ESMO open·2025
Same author

What's Current and What's New in Mesothelioma?

Clinical oncology (Royal College of Radiologists (Great Britain))·2022
Same author

ESMO expert consensus statements on the management of EGFR mutant non-small-cell lung cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2022